The ALS Investment Fund supports and finances biotech companies that develop drugs and diagnostics for the disease ALS (also called Lou Gehrig's disease). The ALS Investment Fund invests globally, with a focus is on Europe and the US.
Phone: +31 20 664 55 00
Johannes Vermeer Plein 9
|2018-07-16||Verge Genomics||Series A||$32M||Agent Capital, DFJ, OS Fund, and WuXi Healthcare Ventures|
|2018-06-19||Emulate||Series C||$36M||Founders Fund, Glass Wall Syndicate, and SciFi VC|
|2017-03-09||Orphazyme||Series B - II||$14.82M||Aescap Venture, IDInvest Partners, Kurma Partners, Life Sciences Partners, Novo Ventures, and Sunstone Capital|
|2016-08-22||Amylyx Pharmaceuticals||Series A||$5M||Henri Termeer, Morningside Venture Capital (晨兴资本), and Radius Ventures|